The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: A systematic review and meta-analysis
Leeflang, M.M.G., Ang, C.W., Berkhout, J., Bijlmer, H.A., Van Bortel, W., Brandenburg, A.H., Van Burgel, N.D., Van Dam, A.P., Dessau, R.B., Fingerle, V., Hovius, J.W.R., Jaulhac, B., Meijer, B., Van Pelt, W., Schellekens, J.F.P., Spijker, R., Stelma, F.F., Stanek, G., Verduyn-Lunel, F., Zeller, H., Sprong, H.
Factsheet about seasonal influenza
Seasonal influenza is a preventable infectious disease with mostly respiratory symptoms. It is caused by influenza virus and is easily transmitted, predominantly via the droplet and contact routes and by indirect spread from respiratory secretions on hands, tissues, etc.
Target 1.1 - Provision and regulation of clinical microbiology services
This target showed fluctuation in the median score despite a narrowing range of performance over time. In 2015, more than 50% of the EU/EEA countries had a score of 7.0 (intermediate: 6.0 to 7.9) or more for this target.
Target 1.2. Diagnostic testing guidelines
Although a continuous positive trend in performance has been observed over time, the widening interquartile ranges still reflect disparity between many countries that also scored low with regard to the availability of national primary diagnostic testing and screening guidelines.
Target 1.3. Diagnostic testing utilisation
This is a weaker target within the primary diagnostic testing dimension. Almost half of the EU/EEA countries are characterised by low capacities in this area. A slight increase of the median score and a narrowing IQR would suggest a gradual improvement.
Target 1.4. Antimicrobial drug susceptibility testing
This target shows rapid improvement over time, with more than 75% of the EU/EEA countries ranking as ‘high capacity/capability’ for harmonised testing in 2015; differences in performance are also narrowing between countries.